ALNY
Alnylam Pharmaceuticals, Inc.
$149.40−7.10 (−4.54%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Jun 1, 2004 – Nov 18, 2026, Dividends reinvested
- Final balance
- $213,429
- CAGR
- +14.60%
- Max drawdown
- −83.58%
Trailing returns (%)
ALNY's average annual return was 12.51% over the last 10 years and 10.50% over the last 20 years, through Nov 18, 2026. $10,000 in ALNY on Nov 18, 2016 grew to $32,492 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −35.56%
- 3M
- −34.65%
- 6M
- −47.81%
- YTD
- −62.43%
- 1Y
- −67.68%
Per year
- 3Y
- −3.01%
- 5Y
- −3.55%
- 10Y
- +12.51%
- 15Y
- +22.39%
- 20Y
- +10.50%
- Since 2004
- +14.60%
Annual returns
2004 from Jun 1 · 2026 through Nov 18
ALNY returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −62.43% |
| 2025 | +68.99% |
| 2024 | +22.94% |
| 2023 | −19.46% |
| 2022 | +40.14% |
| 2021 | +30.48% |
| 2020 | +12.85% |
| 2019 | +57.96% |
| 2018 | −42.61% |
| 2017 | +239.34% |
| 2016 | −60.23% |
| 2015 | −2.95% |
Metrics
Since 2004| Volatility | 57.51% |
|---|---|
| Sharpe ratio | 0.52 |
| Sortino ratio | 0.83 |
| Calmar ratio | 0.17 |
| Longest drawdown | 5.7 years |
Worst drawdowns
Since 2004| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −83.6% | Oct 2007 | Oct 2011 | Jul 2013 | 5.7 years |
| −77.4% | Jun 2015 | Nov 2016 | Nov 2017 | 2.4 years |
| −69.6% | Oct 2025 | Nov 2026 | Not yet | 1.1 years so far |
| −57.8% | Mar 2018 | Dec 2018 | Jun 2020 | 2.3 years |
| −52.2% | Jun 2004 | Aug 2004 | Jan 2005 | 7 months |